Pay in 4 interest-free payments of $5.72 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Liraglutide was the first GLP-1 receptor analogue approved for the management of obesity, thus starting the new era of gastrointestinal peptide agonist pharmacotherapy for the treatment of both diabetes and obesity
This method, primarily in the form of subcutaneous injections, ensures higher bioavailability and effectiveness
All that remains to be seen, and an absolute benefit of 1.5 per 100 people treated is certainly nothing to write home about
Make a conscious effort to avoid touching your face, and keep your hair clean and away from your face
Patch test recommended, apply the product in a small area like the side of the neck and wait for 10 minutes, in case of irritation or reaction, discontinue use
US$ 21.00
US$ 22.76
US$ 26.28
US$ 28.91
US$ 25.47
